Kings and commoners at Copan: Isotopic evidence for origins and movement in the Classic Maya period
Price, T. Douglas, Burton, James H., Sharer, Robert J., Buikstra, Jane E., Wright, Lori E., Traxler, Loa P., Miller, Katherine A.
Published in Journal of anthropological archaeology (01.03.2010)
Published in Journal of anthropological archaeology (01.03.2010)
Get full text
Journal Article
4-(Phenylamino)pyrrolopyrimidines: Potent and Selective, ATP Site Directed Inhibitors of the EGF-Receptor Protein Tyrosine Kinase
Traxler, Peter M, Furet, Pascal, Mett, Helmut, Buchdunger, Elisabeth, Meyer, Thomas, Lydon, Nicholas
Published in Journal of medicinal chemistry (07.06.1996)
Published in Journal of medicinal chemistry (07.06.1996)
Get full text
Journal Article
4,5-Dianilinophthalimide: A Protein-Tyrosine Kinase Inhibitor with Selectivity for the Epidermal Growth Factor Receptor Signal Transduction Pathway and Potent in vivo Antitumor Activity
Buchdunger, Elisabeth, Trinks, Uwe, Mett, Helmut, Regenass, Urs, Muller, Marcel, Meyer, Thomas, McGlynn, Elaine, Pinna, Lorenzo A., Traxler, Peter, Lydon, Nicholas B.
Published in Proceedings of the National Academy of Sciences - PNAS (15.03.1994)
Published in Proceedings of the National Academy of Sciences - PNAS (15.03.1994)
Get full text
Journal Article
Thiazolidine-diones. Biochemical and biological activity of a novel class of tyrosine protein kinase inhibitors
Geissler, J F, Traxler, P, Regenass, U, Murray, B J, Roesel, J L, Meyer, T, McGlynn, E, Storni, A, Lydon, N B
Published in The Journal of biological chemistry (25.12.1990)
Published in The Journal of biological chemistry (25.12.1990)
Get full text
Journal Article
4,5-bis(4-fluoroanilino)phthalimide: A selective inhibitor of the epidermal growth factor receptor signal transduction pathway with potent in vivo antitumor activity
BUCHDUNGER, E, METT, H, LYDON, N. B, TRINKS, U, REGENASS, U, MÜLLER, M, MEYER, T, BEILSTEIN, P, WIRZ, B, SCHNEIDER, P, TRAXLER, P
Published in Clinical cancer research (01.08.1995)
Get full text
Published in Clinical cancer research (01.08.1995)
Journal Article
Sulfonylbenzoyl-nitrostyrenes: Potential bisubstrate type inhibitors of the EGF-receptor tyrosine protein kinase
Traxler, Peter M, Wacker, Oskar, Bach, Ha L, Geissler, Johanna F, Kump, Wilhelm, Meyer, Thomas, Regenass, Urs, Roesel, Johannes L, Lydon, Nicholas
Published in Journal of medicinal chemistry (01.08.1991)
Published in Journal of medicinal chemistry (01.08.1991)
Get full text
Journal Article
AEE788: A dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity
TRAXLER, Peter, ALLEGRINI, Peter R, MEYER, Thomas, TANG, Careen, WARTMANN, Markus, WOOD, Jeanette, CARAVATTI, Giorgio, BRANDT, Ralf, BRUEGGEN, Josef, COZENS, Robert, FABBRO, Doriano, GROSIOS, Konstantina, LANE, Heidi A, MCSHEEHY, Paul, MESTAN, Jürgen
Published in Cancer research (Chicago, Ill.) (15.07.2004)
Published in Cancer research (Chicago, Ill.) (15.07.2004)
Get full text
Journal Article
Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitro
HOUGHTON, Peter J, GERMAIN, Glen S, HARWOOD, Franklin C, SCHUETZ, John D, STEWART, Clinton F, BUCHDUNGER, Elisabeth, TRAXLER, Peter
Published in Cancer research (Chicago, Ill.) (01.04.2004)
Published in Cancer research (Chicago, Ill.) (01.04.2004)
Get full text
Journal Article
Author errata
Lydon, N, Mett, H, Mueller, M, Becker, M, Cozens, R M, Daniels, D, Traxler, P, Buchdunger, E, Stover, D
Published in International journal of cancer (17.05.1999)
Get full text
Published in International journal of cancer (17.05.1999)
Journal Article
Tyrosine kinase inhibitors: From rational design to clinical trials
Traxler, Peter, Bold, Guido, Buchdunger, Elisabeth, Caravatti, Giorgio, Furet, Pascal, Manley, Paul, O'Reilly, Terence, Wood, Jeanette, Zimmermann, Juerg
Published in Medicinal research reviews (01.11.2001)
Published in Medicinal research reviews (01.11.2001)
Get full text
Journal Article
Conference Proceeding
Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma
BRUNS, C. J, SOLORZANO, C. C, FIDLER, I. J, HARBISON, M. T, OZAWA, S, TSAN, R, FAN, D, ABBRUZZESE, J, TRAXLER, P, BUCHDUNGER, E, RADINSKY, R
Published in Cancer research (Chicago, Ill.) (01.06.2000)
Get full text
Published in Cancer research (Chicago, Ill.) (01.06.2000)
Journal Article
Protein kinases as targets for anticancer agents: from inhibitors to useful drugs
Fabbro, Doriano, Ruetz, Stephan, Buchdunger, Elisabeth, Cowan-Jacob, Sandra W, Fendrich, Gabriele, Liebetanz, Janis, Mestan, Jürgen, O'Reilly, Terence, Traxler, Peter, Chaudhuri, Bhabatosh, Fretz, Heinz, Zimmermann, Jürg, Meyer, Thomas, Caravatti, Giorgio, Furet, Pascal, Manley, Paul W
Published in Pharmacology & therapeutics (Oxford) (01.02.2002)
Published in Pharmacology & therapeutics (Oxford) (01.02.2002)
Get full text
Journal Article
Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition
Goudar, Ranjit K, Shi, Qing, Hjelmeland, Mark D, Keir, Stephen T, McLendon, Roger E, Wikstrand, Carol J, Reese, Elizabeth D, Conrad, Charles A, Traxler, Peter, Lane, Heidi A, Reardon, David A, Cavenee, Webster K, Wang, Xiao-Fan, Bigner, Darell D, Friedman, Henry S, Rich, Jeremy N
Published in Molecular cancer therapeutics (01.01.2005)
Published in Molecular cancer therapeutics (01.01.2005)
Get full text
Journal Article
Effect of a novel series of macrocyclic hypolipidemic agents on plasma lipid and lipoprotein levels of four non-primate species
Gibson, J.C., Kothari, H.V., Genthe, T.M., Lee, W.H., Poirier, K.J., Sawyer, W.K., Mugrage, B., Traxler, P., Veenstra, S., Grim, M., Kump, W.
Published in Atherosclerosis (01.10.1992)
Published in Atherosclerosis (01.10.1992)
Get full text
Journal Article
New Anilinophthalazines as Potent and Orally Well Absorbed Inhibitors of the VEGF Receptor Tyrosine Kinases Useful as Antagonists of Tumor-Driven Angiogenesis
Bold, Guido, Altmann, Karl-Heinz, Frei, Jörg, Lang, Marc, Manley, Paul W, Traxler, Peter, Wietfeld, Bernhard, Brüggen, Josef, Buchdunger, Elisabeth, Cozens, Robert, Ferrari, Stefano, Furet, Pascal, Hofmann, Francesco, Martiny-Baron, Georg, Mestan, Jürgen, Rösel, Johannes, Sills, Matthew, Stover, David, Acemoglu, Figan, Boss, Eugen, Emmenegger, René, Lässer, Laurent, Masso, Elvira, Roth, Rosemarie, Schlachter, Christian, Vetterli, Werner, Wyss, Dominique, Wood, Jeanette M
Published in Journal of medicinal chemistry (15.06.2000)
Published in Journal of medicinal chemistry (15.06.2000)
Get full text
Journal Article
ATP site-directed competitive and irreversible inhibitors of protein kinases
García-Echeverría, Carlos, Traxler, Peter, Evans, Dean B.
Published in Medicinal research reviews (01.01.2000)
Published in Medicinal research reviews (01.01.2000)
Get full text
Journal Article